FDA Investigator Adetutu M Gidado

Adetutu M Gidado has conducted inspections on 78 sites in 11 countries as of 25 Apr 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
78
Last Inspection Date:
25 Apr 2024
Investigator Role:
FDA Investigator
Redica ID:
100005596
Countries of Inspections:
United States of America, Taiwan, Canada, Austria, Denmark, India, Switzerland, Mexico, Ireland, Poland, Costa Rica
FDA Investigators that have inspected at least one site in common with Adetutu M Gidado:
Adam R Cooke, Addam S Reynolds, Alan P Kurtzberg, Alberto A Viciedo, Alice S Tsao, Amy L Singer, Amy M Codella, Amy M Cramer, Ana P Pineda Zavaleta, Anastasia M Shields, Anita R Michael, Ankur C Patel, Ann Marie Montemurro, Ann Marie Schofield, Anne E Johnson, Annemarie B Randow, Annemarie Bodnar, Annet R Rajan, Anthony C Warchut, Ashutosh Rao, PhD, Asia D Clark, Atul J Agrawal, Barbara Janine Breithaupt, Barbara Jwilimczyk Macri, Bei Y He, Bonita S Chester, Brian D Nicholson, Bryan L Mcguckin, Cassandra L Abellard, CDR Rochelle B Young, RPh, MSA, Cheryl A Clausen, Christopher T Middendorf, Claire M Minden, Craig D Zagata, Cynthia Jim, CSO, Daniel J Grabicki, Daniel J Min, Daniel J Roberts, Daniel L Zheng, David A Oluwo, Dawn C Olenjack, Dawn L Wydner, Denise M Digiulio, Denise M Visco, Investigator, Devon Jenkins, Dhaval H Patel, Diane C Thibodeau, Dien N Nguyen, Djamila Harouaka, Dolores Harper, Donald C Obenhuber, PhD, Dorothy J Denes, Douglas C Kovacs, Dr. Robert C Horan, MD, Edmund F Mrak, Jr, Elaine E Gilfillan, Emest F Bizjak, Emily A Baldwin, Emmanuel Jramos Maldonado, Eric M Mueller, PharmD, Erika V Butler, Erin D Mccaffery, Esteban Beltran, Felix Maldonado, Frank J Marciniak, Fred Razzaghi, Frederick F Razzaghi, Gabrielle J Swain, Gayle S Lawson, Gerald B Seaborn, Jr, Ginger M Sykes, Gobiga Vanniyasingam, Gregson A Joseph, Guerlain Ulysse, Gwyn G Dickinson, Hala L Selby, Helen B Ricalde, Helen Verdel, Himanshu Gupta, PhD, Jacqueline S Warner, James A Liubicich, James D Bridges, James M Mason, James R Birkenstamm, Jamie L Dion, Janet A Rajan, Javier E Santos, Jay B Shah, Jennifer L Custodio, Jennifer Macmillan, Jenny Sung, Jessica M Monteiro, Jessica S Estriplet, Joel D Hustedt, Jogy George, John A Gonzalez, Jonah S Ufferfilge, Jonathan G Matrisciano, Jonathan S Helfgott, Jonee J Mearns, Jose Acruz Gonzalez, José E Meléndez, Jose M Cayuela, Jose Martinez, Jr, Jose Ohernandez Guzman, Jose R Hernandez, Joseph F Mcginnis, RPh, Josh Renzo N Ramilo, Joy Rkozlowski Klena, Juanita P Versace, Julianne C Mccullough, Julie D Bringger, Junho Pak, Justine Tomasso, Kalavati Suvarna, PhD, Karen E D'orazio, Karishma G Gopaul, Katherine Szestypalow, Kelli F Dobilas, Kelly N Kerr, Kendra L Brooks, Kenneth M Gordon, Kevin A Gonzalez, Kevin P Foley, Kim Lthomas Cruse, Kimberly M White, Ko U Min, Kristen D Evans, Kristen E Rescigno, Kristina L Conroy, Kristy A Zielny, Lakshmi Narasimhan, PhD, Larry K Austin, Lata C Mathew, PhD, Laura Fontan, MS, Lauren L Vajo, Leonard H Lavi, Li Li, Liatte Kreuger, PharmD, Loretta Nemchik, Lourdes Valentin Aponte, Lucas B Leake, Luis A Dasta, Marcelo O Mangalindan, Jr, Marea K Harmon, Margaret M Annes, Margaret M Sands, Maria Estrella, Mark R Mcclain, Marybet Lopez Negron, Mathew T Thomas, MD, Matthew R Dionne, Maya M Davis, Mayar M Mussa, Melanie M Walker, Melissa J Garcia, Melissa T Roy, Meredith L Sheridan, Meyer J Slobotsky, Michael A Charles, Michael E Maselli, Michael R Goga, Michael R Klapal, Michael Serrano, Miguel A Martinez Perez, Mina D Ahmadi, Mindy M Chou, Nadeem I Chaudhry, Nancy F Scheraga, Nancy L Rolli, Nancy M Espinal, Natasha Gupta, Nealie C Newberger, Nerizza B Guerin, Nicholas A Violand, Niketa Patel, Nikisha M Bolden, Nina Yang, Odera I Ekwunife, Parul M Patel, Patricia F Hughes, PhD, Patrick C Klotzbuecher, Patsy J Domingo, Paul L Bellamy, Paul L Figarole, Jr, Paula J Bretz, Peter R Lenahan, Pratibha Bhat, Puspa Suresh Jayasekara, Rafael Nevarez Nieves, Reba A Gates, Rebecca Rodriguez, Regina T Brown, Reyes Candau Chacon, PhD, Richard E Needham, Richard Ledwidge (nmi), PhD, Robert C Coleman, Robert J Martin, Robert Jennings, Robin P Mathew, Rochelle K Kimmel, Ronald G Crawford, Rose Ashley, Rose Ljean Mary, Russell J Glapion, Russell K Riley, Saleem A Akhtar, Samantha J Bradley, Samir C Gala, Sandra A Boyd, Sarah Adella Fave, Sarah Forney, Satheesh K Podaralla, Sayyem H Akbar, Scott T Ballard, Sean G Casey, Sena G Dissmeyer, Sharon K Thoma, PharmD, Shirley S Wen, Sixto M Mercado Rios, Srinivas R Chennamaneni, PhD, Sripal R Mada, PhD, Stelios C Tsinontides, Stephanie T Durso, Stephen J Koniers, Stephen J Mottola, Stephenie M Ortiz, Steven D Kehoe, Suchan Kim, Susan M Halsted, Susan M Jackson, Susan T Hadman, Susan Yu, Tamil Arasu, PhD, Tanya R Syffrard, Tara G Bizjak, Tara R Gooen, Thomas E Friel, Torrance J Slayton, Toyin B Oladimeji, Truong Xuan Nguyen (Andy), Tyanna N Hadley, Unnee Ranjan, Victoria Spivak, Vilmary Negron Rodriguez, Vlada Matusovsky, Wayne D Mcgrath, William R Chang, Xiaohan Cai, PhD, Yiyue Zhang (nmi), PhD, Yong Wu, PhD, Yvesna C Blaise, Yvins Dezan, Zhong Li, PhD

Adetutu M Gidado's Documents

Publish Date Document Type Title
September, 2016 FDA 483 Response New Jersey Laboratories - Form 483R, 2016-10-11
August, 2021 FDA 483 Water-Jel Technologies - Form 483, 2021-08-18
July, 2019 FDA 483 Unichem Laboratories Limited - Form 483, 2019-07-31
January, 2020 FDA 483 HOVIONE LLC - Form 483, 2020-01-22
December, 2019 FDA 483 Tulex Pharmaceuticals Inc - Form 483, 2019-12-12
December, 2021 FDA 483 INVAHEALTH INC. - Form 483, 2021-12-15
August, 2020 EIR Kobo Products, Inc - EIR, 2020-08-18
March, 2023 FDA 483 EzriCare, LLC. - Form 483, 2023-03-21
January, 2019 EIR Productos Quimicos Naturales S.A. de C.V. - EIR, 2019-01-25
December, 2016 FDA 483 Guardian Drug Company - Form 483, 2016-12-06
September, 2016 FDA 483 New Jersey Laboratories - Form 483, 2016-09-23
June, 2022 FDA 483 Mandell's Clinical Pharmacy - Form 483, 2022-06-17
September, 2021 FDA 483 Premier Trends LLC - Form 483, 2021-09-29
November, 2021 FDA 483 Suite K Value Added Services LLC - Form 483, 2021-11-02
July, 2017 FDA 483 Amneal Pharmaceuticals, LLC - Form 483, 2017-07-27
April, 2016 FDA 483 Alliance Technologies, LLC - Form 483, 2016-04-15
February, 2019 FDA 483 Polimeros y Servicios S.A. - Form 483, 2019-02-15
March, 2017 FDA 483 Response Tris Pharma Inc - Form 483R, 2017-03-20
July, 2017 EIR Amneal Pharmaceuticals, LLC - EIR, 2017-07-27
March, 2022 FDA 483 Novel Laboratories, Inc. - Form 483, 2022-03-30
September, 2022 FDA 483 A/S Orthana Kemisk Fabrik - Form 483, 2022-10-21
January, 2016 FDA 483 Davlyn Industries Inc. - Form 483, 2016-01-11
March, 2018 FDA 483 Sun Pharmaceutical Industries, Inc. - Form 483, 2018-03-09
October, 2018 FDA 483 ENDO USA, Inc. - Form 483, 2018-12-10
February, 2019 FDA 483 Compañía Internacional de Comercio, S.A.P.I. de C.V. - Form 483, 2019-02-01
March, 2016 FDA 483 SPECTRUM LABORATORY PRODUCTS INC. dba SPECTRUM CHEMICAL MFG. CORP. - Form 483, 2016-03-14
March, 2017 FDA 483 Tris Pharma Inc - Form 483, 2017-03-20
April, 2016 FDA 483 Akorn Operating Company LLC (dba Akorn) - Form 483, 2016-04-04
August, 2020 FDA 483 Kobo Products, Inc - Form 483, 2020-08-18
September, 2016 EIR New Jersey Laboratories - EIR, 2016-09-23
June, 2023 EIR Renaissance Lakewood LLC - EIR, 2023-06-06
November, 2019 EIR Camber Pharmaceuticals, Inc. - EIR, 2019-11-25
September, 2022 EIR A/S Orthana Kemisk Fabrik - EIR, 2022-11-04
June, 2018 FDA 483 Aurolife Pharma LLC - Form 483, 2018-06-14
January, 2017 FDA 483 Cosette Pharmaceuticals, Inc. - Form 483, 2017-01-26
May, 2022 FDA 483 Vantage Specialty Ingredients, Inc - Form 483, 2022-05-02
July, 2016 FDA 483 Response Actavis LLC - Form 483R, 2016-07-28
June, 2017 EIR InvaDerm Corporation - EIR, 2017-06-15
January, 2020 EIR HOVIONE LLC - EIR, 2020-01-22
May, 2018 FDA 483 Advanced Accelerator Applications USA, Inc. - Form 483, 2018-05-17
July, 2016 FDA 483 Actavis LLC - Form 483, 2016-07-07
June, 2023 FDA 483 Renaissance Lakewood LLC - Form 483, 2023-06-06
April, 2016 FDA 483 Response Akorn Operating Company LLC (dba Akorn) - Form 483R, 2016-04-26
December, 2023 FDA 483 Primera Analytical Solutions Corporation - Form 483, 2023-12-12
November, 2022 FDA 483 HOVIONE LLC - Form 483, 2022-11-17
March, 2018 EIR Sun Pharmaceutical Industries, Inc. - EIR, 2018-03-09
May, 2017 EIR InvaDerm Corporation - EIR, 2017-05-30
May, 2019 FDA 483 A.P. Deauville, LLC - Form 483, 2019-05-02
October, 2019 FDA 483 Milbar Laboratories, Inc. - Form 483, 2019-10-11
June, 2021 FDA 483 Tris Pharma Inc - Form 483, 2021-06-08
March, 2019 FDA 483 InvaDerm Corporation - Form 483, 2019-03-26
December, 2017 FDA 483 Hikma Injectables USA Inc. - Form 483, 2017-12-13
October, 2018 FDA 483 Response ENDO USA, Inc. - Form 483R, 2018-11-08
July, 2018 FDA 483 Genus Lifesciences Inc. - Form 483, 2018-07-20
July, 2016 EIR Actavis LLC - EIR, 2016-07-07
September, 2017 FDA 483 HK Kolmar Canada, Inc - Form 483, 2017-09-29
August, 2020 FDA 483 Response Kobo Products, Inc - Form 483R, 2020-08-18
December, 2015 FDA 483 L'OREAL USA, INC. - Form 483, 2015-12-09
June, 2024 FDA 483 Advanced Accelerator Applications USA, Inc. - Form 483, 2024-06-27
June, 2019 FDA 483 Premier Trends LLC - Form 483, 2019-06-28

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more